Categories

“Beyond the Bubble Bath,” Self-Care Must Be Rooted in Science To Build Trust Among Consumers

The goal of self-care for health-making is to improve lives by scaling health-and-wellness accessible to all, Bayer believes, giving people more control over their personal health. Self-care work-flows must be based in science to ensure products and services are trusted and deliver on their clinical promise, Bayer explains in Science-Led Self-Care: Principles for Best Practice, a paper published this week which the company intends to be a blueprint for the industry.                 Bayer recognizes that self-care is growing among health consumers around the world — albeit underpinned by peoples’ cultures, demographics, and “readiness”

Comments(0)

Health, Politics, Inflation and Women: Health Engagement at the Voting Booth

Two in three Americans disapproved of the Supreme Court’s decision to overturn the Roe v. Wade decision (aka the Dobbs case), the latest Kaiser Family Foundation Health Tracking Poll found. While inflation tops voters’ priorities, abortion access resonates for key voting blocs. KFF conducted this survey among 1,847 U.S. adults 18 and over between July 7 and 17, 2022.             KFF published the study findings this week on August 2, a day of political primaries and ballot considerations in several U.S. states. Consider Kansas: a majority of Kansans voted on Tuesday to protect abortion rights

Comments(0)

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

When I talk about patient support programs (PSPs), I’m most often focused on supporting peoples’ access to medicines due to costs, bolstering health literacy, and addressing health citizens’ risks of drivers of health that can be obstacles to optimal health outcomes (those challenging social determinants of health). A new report from Deloitte on Intelligent post-launch patient support speaks to another crucial definition of patient support: post-market surveillance and patient safety.                 The paper’s central thesis is that improving patient support is a critical step in the biopharma value chain, illustrated in the first diagram

Comments(0)